Edward L. Mattiuz

904 total citations
14 papers, 602 citations indexed

About

Edward L. Mattiuz is a scholar working on Pharmacology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Edward L. Mattiuz has authored 14 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in Edward L. Mattiuz's work include Pharmacogenetics and Drug Metabolism (7 papers), Schizophrenia research and treatment (5 papers) and Tryptophan and brain disorders (4 papers). Edward L. Mattiuz is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Schizophrenia research and treatment (5 papers) and Tryptophan and brain disorders (4 papers). Edward L. Mattiuz collaborates with scholars based in United States. Edward L. Mattiuz's co-authors include Kelem Kassahun, Todd A. Gillespie, Anthony Murphy, G. Douglas Ponsler, John‐Michael Sauer, Louis Lemberger, David E. Tupper, Boyd D. Obermeyer, Amanda Long and Jennifer Witcher and has published in prestigious journals such as Drug Metabolism and Disposition, Clinical and Experimental Pharmacology and Physiology and Journal of Pharmacological and Toxicological Methods.

In The Last Decade

Edward L. Mattiuz

14 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward L. Mattiuz United States	10	267	175	143	123	76	14	602
I. Gaertner Germany	12	320 1.2×	149 0.9×	171 1.2×	110 0.9×	156 2.1×	13	715
Androniki E. Balant-Gorgia Switzerland	10	258 1.0×	129 0.7×	167 1.2×	52 0.4×	75 1.0×	11	574
Jeffrey Alderman United States	12	209 0.8×	214 1.2×	163 1.1×	119 1.0×	49 0.6×	19	774
Lawrence J. Albers United States	16	286 1.1×	181 1.0×	162 1.1×	150 1.2×	199 2.6×	26	781
Gabriel Eckermann Germany	9	385 1.4×	123 0.7×	213 1.5×	111 0.9×	94 1.2×	24	766
Barry D. Zussman United Kingdom	15	253 0.9×	218 1.2×	344 2.4×	152 1.2×	138 1.8×	20	915
T. Aaes‐Jørgensen Denmark	13	270 1.0×	200 1.1×	249 1.7×	95 0.8×	123 1.6×	24	820
E. D. Korchinski Canada	19	240 0.9×	276 1.6×	127 0.9×	126 1.0×	112 1.5×	31	712
K. Sugawara Japan	14	121 0.5×	174 1.0×	152 1.1×	92 0.7×	77 1.0×	29	537
Gabriella Facciolà Italy	10	446 1.7×	281 1.6×	140 1.0×	73 0.6×	47 0.6×	11	738

Countries citing papers authored by Edward L. Mattiuz

Since Specialization

Citations

This map shows the geographic impact of Edward L. Mattiuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward L. Mattiuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward L. Mattiuz more than expected).

Fields of papers citing papers by Edward L. Mattiuz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward L. Mattiuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward L. Mattiuz. The network helps show where Edward L. Mattiuz may publish in the future.

Co-authorship network of co-authors of Edward L. Mattiuz

This figure shows the co-authorship network connecting the top 25 collaborators of Edward L. Mattiuz. A scholar is included among the top collaborators of Edward L. Mattiuz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward L. Mattiuz. Edward L. Mattiuz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Jones, Timothy M., Robert J. Barbuch, David A. Jackson, et al.. (2011). Metabolism of LY654322, a Growth Hormone Secretagogue, to an Unusual Diimidazopyridine Metabolite. Drug Metabolism and Disposition. 39(5). 740–749. 1 indexed citations

Kulanthaivel, Palaniappan, Robert J. Barbuch, Ping Yi, et al.. (2004). SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM. Drug Metabolism and Disposition. 32(9). 966–972. 48 indexed citations

Sauer, John‐Michael, G. Douglas Ponsler, Edward L. Mattiuz, et al.. (2003). Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism. Drug Metabolism and Disposition. 31(1). 98–107. 118 indexed citations

Perkins, E.J., John W. Cramer, Nazar Farid, et al.. (2003). PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS. Drug Metabolism and Disposition. 31(11). 1382–1390. 8 indexed citations

Mattiuz, Edward L., G. Douglas Ponsler, Robert J. Barbuch, et al.. (2003). Disposition and Metabolic Fate of Atomoxetine Hydrochloride: Pharmacokinetics, Metabolism, and Excretion in the Fischer 344 Rat and Beagle Dog. Drug Metabolism and Disposition. 31(1). 88–97. 35 indexed citations

Mattiuz, Edward L., et al.. (2002). The Disposition, Metabolism, and Pharmacokinetics of a Selective Metabotropic Glutamate Receptor Agonist in Rats and Dogs. Drug Metabolism and Disposition. 30(1). 27–33. 19 indexed citations

Soars, Matthew G., Edward L. Mattiuz, David A. Jackson, et al.. (2002). Biosynthesis of drug glucuronides for use as authentic standards. Journal of Pharmacological and Toxicological Methods. 47(3). 161–168. 21 indexed citations

Schenker, S., et al.. (1999). Olanzapine Transfer By Human Placenta. Clinical and Experimental Pharmacology and Physiology. 26(9). 691–697. 28 indexed citations

Mattiuz, Edward L., et al.. (1999). Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 726(1-2). 203–209. 44 indexed citations

10.

Kassahun, Kelem, Edward L. Mattiuz, Ronald B. Franklin, & Todd A. Gillespie. (1998). Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humans.. PubMed. 26(9). 848–55. 37 indexed citations

11.

Kassahun, Kelem, Edward L. Mattiuz, Boyd D. Obermeyer, et al.. (1997). Disposition and biotransformation of the antipsychotic agent olanzapine in humans.. PubMed. 25(1). 81–93. 187 indexed citations

12.

Mattiuz, Edward L., et al.. (1997). Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.. PubMed. 25(5). 573–83. 45 indexed citations

13.

Mattiuz, Edward L., K A DeSante, Alan P. Breau, et al.. (1993). Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans.. Drug Metabolism and Disposition. 21(2). 249–254. 4 indexed citations

14.

Mattiuz, Edward L., James W. Webb, & Stephen C. Gates. (1982). High Resolution Separation of Urinary Organic Acids by High Performance Liquid Chromatography. Journal of Liquid Chromatography. 5(12). 2343–2357. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact